Stay updated on T-DXd Combos in HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd Combos in HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd Combos in HER2+ MBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T16:34:27.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T16:43:13.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    On this page, the study record now displays a 403 Forbidden error screen, replacing the usual study details and navigation. This error indicates the page is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-20T20:12:39.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Funding sources listing updated to include 2019 and 2023 NIH grants/contracts. The page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T19:17:51.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a post-update revision of the page or site software.
    Difference
    0.0%
    Check dated 2026-08-09T07:51:10.000Z thumbnail image
  6. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added to the page, and Revision: v3.6.3 was removed. This updates the page's version metadata and does not change user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T18:06:51.000Z thumbnail image

Stay in the know with updates to T-DXd Combos in HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd Combos in HER2+ MBC Clinical Trial page.